Seattle company’s cannabis candies could fuel boom in stock shares
A popular Seattle cannabis manufacturer recently announced the roll-out of an all-new line of premium infused edibles, marketed under the brand name “Goodies.” Hand-crafted, gluten-free, and using all-natural ingredients, the candies and caramels contain micro-dose servings of just 5-mg THC for a controlled, measured experience.
Get a FREE report on new pot stock blockbuster

CPH Insider Trading (Creso Pharma)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$4,498,166.62

Creso Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Creso Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Creso Pharma Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 01/1/2000 01:00 AM ET

This chart shows the closing price history over time for CPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
pixel

Creso Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/14/2021Adam BlumenthalInsiderIssued12,000,000A$0.13A$1,560,000.00
7/7/2021Adam BlumenthalInsiderSell32,833,333A$0.14A$4,498,166.62
12/23/2020Adam BlumenthalInsiderIssued137,457,045A$0.03A$3,986,254.31
10/12/2020Miriam WernliInsiderIssued833,333A$0.06A$49,999.98
See Full Table
Insider Buying at Creso Pharma?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Creso Pharma and related companies.

SEC Filings (Institutional Ownership Changes) for Creso Pharma (ASX:CPH)

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates and harvests cannabis plants, as well as supplies dried cannabis plant retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions in humans; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. The company also offers nutraceutical products, such as cannaQIX, a hemp oil-derived food supplement under the Cannamics brand. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
Read More on Creso Pharma

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Creso Pharma?

Creso Pharma's top insider investors include:
  1. Adam Blumenthal (Insider)
  2. Miriam Wernli (Insider)
Seattle company’s cannabis candies could fuel boom in stock shares
A popular Seattle cannabis manufacturer recently announced the roll-out of an all-new line of premium infused edibles, marketed under the brand name “Goodies.” Hand-crafted, gluten-free, and using all-natural ingredients, the candies and caramels contain micro-dose servings of just 5-mg THC for a controlled, measured experience.
Get a FREE report on new pot stock blockbuster